Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
20 p, 2.6 MB Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease / Carvajal, Silvia (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Perramón, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Oró, Denise (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Casals, Eudald (Wuyi University. School of Biotechnology and Health Sciences) ; Fernández Varo, Guillermo (Universitat de Barcelona. Departament de Biomedicina) ; Parra-Robert, Marina (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; González de la Presa, Bernardino. (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Ribera, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Pastor, Óscar (Hospital Universitario Ramón y Cajal. Servicio de Bioquímica Clínica) ; Morales Ruiz, Manuel (Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Jiménez, Wladimiro (Universitat de Barcelona. Departament de Biomedicina)
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO₂NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experimental liver disease. [...]
2019 - 10.1038/s41598-019-49262-2
Scientific reports, Vol. 9 (2019) , art. 12848  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.